News
-
-
-
-
PRESS RELEASE
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential -
-
-
-
-
-
PRESS RELEASE
SFC Energy AG receives first order for newly developed EFOY ProShelter hybrid system to supply critical telecommunications infrastructure in Canada
SFC Energy AG receives first order for EFOY ProShelter hybrid system to power critical telecom infrastructure in Canada, offering sustainable off-grid power solutions